World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
97
Citations
45331
World Ranking
807
National Ranking
1

Medicine

D-Index
97
Citations
45531
World Ranking
9124
National Ranking
1

Gabriel A. Rabinovich publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gabriel A. Rabinovich sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 405 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gabriel A. Rabinovich D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gabriel A. Rabinovich sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 97 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2016 - Member of the National Academy of Sciences
  • 2015 - Fellow, The World Academy of Sciences
  • 2006 - Fellow of John Simon Guggenheim Memorial Foundation

Overview

Gabriel A. Rabinovich is affiliated with the Experimental Medicine and Biology Institute in Argentina. Their research primarily spans the fields of Immunology and Microbiology, Biochemistry, Genetics and Molecular Biology, and Medicine, with a notable focus on Immunology, Molecular Biology, Oncology, Genetics, and Infectious Diseases.

The scientist's work covers several main topics related to their fields, including:

  • Galectins and Cancer Biology
  • Glycosylation and Glycoproteins Research
  • Immune Cell Function and Interaction
  • Signaling Pathways in Disease
  • Toxin Mechanisms and Immunotoxins
  • Immunotherapy and Immune Responses
  • Peptidase Inhibition and Analysis

Gabriel A. Rabinovich's recent notable papers include:

  • "Targeting galectin-driven regulatory circuits in cancer and fibrosis," 2023, Nature Reviews Drug Discovery
  • "Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection," 2023, Cellular and Molecular Immunology
  • "Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarmin," 2021, Nature Immunology
  • "Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8 + regulatory T cells," 2021, Proceedings of the National Academy of Sciences
  • "Single-cell profiling reveals an endothelium-mediated immunomodulatory pathway in the eye choroid," 2020, The Journal of Experimental Medicine

Their frequent co-authors are:

  • Karina V. Mariño
  • Diego O. Croci
  • Alejandro J. Cagnoni
  • Ada G. Blidner
  • Joaquín P. Merlo

Gabriel A. Rabinovich has published frequently in venues such as:

  • Cancer Research
  • Proceedings of the National Academy of Sciences
  • Journal of Biological Chemistry
  • Glycobiology
  • International Journal of Molecular Sciences

The scientist has been recognized with several awards including:

  • Member of the National Academy of Sciences, 2016
  • Fellow, The World Academy of Sciences, 2015
  • Fellow of John Simon Guggenheim Memorial Foundation, 2006

Best Publications

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  • Immunosuppressive Strategies that are Mediated by Tumor Cells

    Gabriel Adrián Rabinovich;Dmitry Gabrilovich;Eduardo Sotomayor

  • Galectins as modulators of tumour progression

    Fu Tong Liu;Gabriel Adrián Rabinovich

  • A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds

    Albana Cumashi;Natalia A. Ushakova;Marina E. Preobrazhenskaya;Armida D'Incecco

  • Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

    L. Galluzzi;J. M. Bravo-San Pedro;I. Vitale;S. A. Aaronson

  • Galectins: structure, function and therapeutic potential.

    Ri Yao Yang;Gabriel A. Rabinovich;Fu Tong Liu

  • Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation.

    Gabriel A. Rabinovich;Marta A. Toscano

  • Protein-glycan interactions in the control of innate and adaptive immune responses

    Yvette Van Kooyk;Gabriel Adrián Rabinovich

  • Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

    L. Galluzzi;L. Galluzzi;L. Galluzzi;S. A. Aaronson;J. Abrams;E. S. Alnemri

  • Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?

    Gabriel Adrián Rabinovich;Linda Gwen Baum;N. Tinari;Roberto Paganelli

  • Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege.

    Natalia Rubinstein;Mariano Alvarez;Norberto Walter Zwirner;Marta Alicia Toscano

  • Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death.

    Marta A Toscano;Germán A Bianco;Germán A Bianco;Juan M Ilarregui;Juan M Ilarregui;Diego O Croci;Diego O Croci

  • Consensus guidelines for the use and interpretation of angiogenesis assays

    Patrycja Nowak-Sliwinska;Kari Alitalo;Elizabeth Allen;Andrey Anisimov

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • A pivotal role for galectin-1 in fetomaternal tolerance

    Sandra M Blois;Juan M Ilarregui;Mareike Tometten;Mariana Garcia

  • Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors

    Diego O. Croci;Juan P. Cerliani;Tomas Dalotto-Moreno;Santiago P. Méndez-Huergo

  • Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10

    Juan M Ilarregui;Diego O Croci;Diego O Croci;Germán A Bianco;Germán A Bianco;Marta A Toscano;Marta A Toscano

  • Galectins: regulators of acute and chronic inflammation

    Fu-Tong Liu;Gabriel Adrian Rabinovich

  • Functions of cell surface galectin-glycoprotein lattices.

    Gabriel Adrián Rabinovich;Gabriel Adrián Rabinovich;Marta Alicia Toscano;Shawn S. Jackson;Gerardo R. Vasta

  • Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis

    Gabriel A. Rabinovich;Gordon Daly;Hanna Dreja;Hitakshi Tailor

Frequent Co-Authors

Margaret A. Shipp
Margaret A. Shipp Harvard University
Fu-Tong Liu
Fu-Tong Liu Academia Sinica
Françoise Poirier
Françoise Poirier Université Paris Cité
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Gerry Melino
Gerry Melino University of Rome Tor Vergata
Carmen Garrido
Carmen Garrido University of Burgundy
Guido Kroemer
Guido Kroemer Université Paris Cité
Jeffery L. Kutok
Jeffery L. Kutok Epizyme (United States)
Beth Levine
Beth Levine The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students transition from foundational nursing roles to more specialized fields, such as acute care nursing. For example, understanding how to transition from fnp to acnp pathways can be crucial for nurses aiming to expand their expertise in critical care settings.

Accelerated study options are also popular among students looking to fast-track their careers. Programs like the accelerated nurse practitioner programs allow students to complete their education efficiently without compromising quality. These online programs often cater to busy professionals by offering flexible schedules.

For non-nurses interested in entering the healthcare field, there are online pathways such as online RN programs for non nurses in Florida. These programs are designed to prepare students from other academic backgrounds for a nursing career, providing comprehensive training that aligns with practical requirements.

Additionally, many students seek programs with high acceptance rates to ensure a smoother admission process. Exploring absn programs with high acceptance rates can help prospective nurses find opportunities that match their academic profiles and accelerate their entry into the field.

Best Scientists Citing Gabriel A. Rabinovich

Trending Scientists

Recently Published Articles